ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve ...
The weekly combination therapy is intended for adults with poor glucose control despite basal insulin or GLP-1 receptor agonist treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback